BlackRock
BIAF icon

BlackRock’s bioAffinity Technologies BIAF Stock Holding History

BlackRock’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.2K Buy
+98,777
New +$202K ﹤0.01% 5055

Other funds holding BIAF

JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ECM
EMC Capital Management Houston, Texas $253M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BlackRock's BIAF Position: Q2 2026 in Review

BlackRock opened a new position in bioAffinity Technologies (BIAF) in Q2 2026: 98,777 shares worth $80.2K. The stake represents ﹤0.01% of the portfolio and ranks #5055 among its holdings.

12 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • BlackRock held 98,777 shares of bioAffinity Technologies worth $80.2K as of Q2 2026.
  • bioAffinity Technologies was a new BlackRock position in Q2 2026.
  • bioAffinity Technologies made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5055 holding.
  • 12 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.